Home » Topics » Regulatory

Regulatory
RSS

Shire submits NDA for once-daily Adderall for ADHD

Oct. 13, 2000

FDA approves first and only once-monthly contraceptive for women

Oct. 10, 2000

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Oct. 5, 2000

First prescription drug to treat unwanted facial hair introduced in U.S.

Oct. 5, 2000

FDA approves breath-activated device with corticosteroid for asthma

Oct. 5, 2000

Novo Nordisk's liquid Norditropin now available in U.S.

Oct. 5, 2000

BLA supplement filed for alteplase

Oct. 4, 2000

FDA approves cream formulation of Allergan's Tazorac

Oct. 4, 2000

FDA approves Fosamax for use in men with osteoporosis

Oct. 3, 2000

First approval for recombinant drug for infertility

Oct. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026